Bcl-2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemBcl-2 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-29214
Gene NameB-cell leukemia/lymphoma 2
Quantity10 µM
Specieshuman
NCBI Full Gene NameBCL2 apoptosis regulator
NCBI Gene AliasesBcl-2, PPP1R50
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cellsCell death & diseaseJanuary 10, 2022Yu Y, Liu B, Li X, Lu D, Yang L, Chen L, Li Y, Cheng L, Lv F, Zhang P, et al.

(2) δ-Catenin promotes cell migration and invasion via Bcl-2-regulated suppression of autophagy in prostate cancer cellsAmerican journal of cancer researchJanuary 1, 2022Chen Z, Lee HJ, Kim H, Cho S, Kim K.

(3) Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma PopulationPathology oncology research : PORJanuary 1, 2021Du H, Luo F, Shi M, Che J, Zhu L, Li H, Hang J.

(4) Antiglioma Potential of Coumarins Combined with SorafenibMolecules (Basel, Switzerland)November 8, 2020Sumorek-Wiadro J, Zając A, Langner E, Skalicka-Woźniak K, Maciejczyk A, Rzeski W, Jakubowicz-Gil J.

(5) Long-term arsenite exposure decreases autophagy by increased release of Nrf2 in transformed human keratinocytesThe Science of the total environmentSeptember 10, 2020Wu J, Ni Y, Yang Q, Mao J, Zhu X, Tao S, Kato K, Zhang J, Wang D, Yamanaka K, et al.

(6) Coumarins modulate the anti-glioma properties of temozolomideEuropean journal of pharmacologyAugust 15, 2020Sumorek-Wiadro J, Zając A, Bądziul D, Langner E, Skalicka-Woźniak K, Maciejczyk A, Wertel I, Rzeski W, Jakubowicz-Gil J.

(7) Aspirin Induced Glioma Apoptosis through Noxa UpregulationInternational journal of molecular sciencesJune 13, 2020Chang CY, Pan PH, Li JR, Ou YC, Wang JD, Liao SL, Chen WY, Wang WY, Chen CJ.

(8) Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma ModelsCancersFebruary 1, 2020Cucarull B, Tutusaus A, Subías M, Stefanovic M, Hernáez-Alsina T, Boix L, Reig M, García de Frutos P, Marí M, Colell A, et al.blotting substrate was from Pierce (Thermo Fisher Scientific, Rockford, IL, USA). BCL-2 siRNA (h) (sc-29214), BCL-xL siRNA (h) (sc-43630), and scrambled controls were purchased from Santa Cruz Biotechnology (Dallas,

(9) miR-34a-5p was involved in chronic intermittent hypoxia-induced autophagy of human coronary artery endothelial cells via Bcl-2/beclin 1 signal transduction pathwayJournal of cellular biochemistryNovember 1, 2019Lv X, Wang K, Tang W, Yu L, Cao H, Chi W, Wang B.

(10) Upregulated cyclin B1/CDK1 mediates apoptosis following 2-methoxyestradiol-induced mitotic catastrophe: Role of Bcl-X(L) phosphorylationSteroidsOctober 1, 2019Choi HJ, Zhu BT.

(11) Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathwaysInternational immunopharmacologyAugust 1, 2019Zhang C, An R, Bao YW, Meng XM, Wang TQ, Sun HN, Pan FM, Zhang C.

(12) Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2OncoTargets and therapyJanuary 1, 2019Yang Y, Li S, Sun Y, Zhang D, Zhao Z, Liu L.

(13) Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKLCell death discoveryJanuary 1, 2019Shi CS, Kehrl JH.

(14) Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinomaOncotargetMarch 30, 2018Tutusaus A, Stefanovic M, Boix L, Cucarull B, Zamora A, Blasco L, de Frutos PG, Reig M, Fernandez-Checa JC, Marí M, et al.western blotting substrate was from Pierce (Thermo Fisher Scientific, Rockford, IL). BCL-2 siRNA (h) (sc-29214), BCL-xL siRNA (h) (sc-43630), MCL-1 siRNA (h) (sc-35877) and scrambled controls were purchased from

(15) miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cellsOncoTargets and therapyJanuary 1, 2018Meng X, Fu R.

(16) microRNA-143 acts as a suppressor of hemangioma growth by targeting Bcl-2GeneSeptember 10, 2017Huang C, Huang J, Ma P, Yu G.

(17) Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinomaCell cycle (Georgetown, Tex.)July 18, 2017Lu Y, Huang H, Yang H, Chen D, Wu S, Jiang Z, Wang R.

(18) Quercetin induces protective autophagy and apoptosis through ER stress via the p-STAT3/Bcl-2 axis in ovarian cancerApoptosis : an international journal on programmed cell deathApril 1, 2017Liu Y, Gong W, Yang ZY, Zhou XS, Gong C, Zhang TR, Wei X, Ma D, Ye F, Gao QL.

(19) Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosisCancer cell internationalJanuary 1, 2017Zhou QM, Sun Y, Lu YY, Zhang H, Chen QL, Su SB.transfection was performed 24 h before curcumin and MMC treatment. siRNA duplexes, including Bcl-2 siRNA (sc-29214) and control scrambled siRNA (sc-37007), were obtained from Santa Cruz Biotechnology. Flow cytometry analysis

(20) Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancerEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.VDecember 1, 2016Büyükköroğlu G, Şenel B, Başaran E, Yenilmez E, Yazan Y.

Be the First to Write a Review!

Bcl-2 siRNA (h)

Bcl-2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (59)

Reviews

Bcl-2 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map